Ocrevus 300 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DB25FAWX5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $64,452
Award facts
- Contract value 100% obligated
- $64,452.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $64,452.33 on May 20, 2025, for the supply of Ocrevus (ocrelizumab) 300 mg/10 mL vials. This is a firm fixed-price, non-set-aside contract with performance completion expected by June 11, 2025, and fulfillment from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 potential value through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
AmerisourceBergen Drug Corp is one of the nation's leading pharmaceutical distributors and was competitively selected to fulfill this medical procurement need through open competition. The company's extensive portfolio with DLA encompasses a broad range of therapeutic pharmaceuticals and medical supplies, including specialty medications, brand-name and generic drugs, and medical devices. This award supports the Defense Health Agency and broader Department of Defense healthcare operations, which rely on AmerisourceBergen's critical role as a prime vendor in the medical supply chain serving military personnel and veteran healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DB25FAWX5?
SPE2DB25FAWX5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 20, 2025.
How much is contract SPE2DB25FAWX5 worth?
The government has obligated $64,452 on SPE2DB25FAWX5.
Is contract SPE2DB25FAWX5 an order under another contract?
Yes. SPE2DB25FAWX5 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FAWX5 competed?
The extent of competition for SPE2DB25FAWX5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award